Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

CASI Pharmaceuticals (CASI) Net Margin (2022 - 2025)

Historic Net Margin for Pharmaceuticals (CASI) over the last 4 years, with Q2 2025 value amounting to 259.54%.

  • Pharmaceuticals' Net Margin fell 468300.0% to 259.54% in Q2 2025 from the same period last year, while for Jun 2025 it was 204.29%, marking a year-over-year decrease of 924700.0%. This contributed to the annual value of 133.4% for FY2024, which is 551300.0% down from last year.
  • According to the latest figures from Q2 2025, Pharmaceuticals' Net Margin is 259.54%, which was down 468300.0% from 161.94% recorded in Q1 2025.
  • Pharmaceuticals' Net Margin's 5-year high stood at 48.01% during Q4 2023, with a 5-year trough of 475.48% in Q4 2022.
  • Moreover, its 4-year median value for Net Margin was 91.2% (2023), whereas its average is 155.97%.
  • Its Net Margin has fluctuated over the past 5 years, first surged by 4274700bps in 2023, then plummeted by -1814400bps in 2024.
  • Over the past 4 years, Pharmaceuticals' Net Margin (Quarter) stood at 475.48% in 2022, then surged by 90bps to 48.01% in 2023, then crashed by -343bps to 212.72% in 2024, then decreased by -22bps to 259.54% in 2025.
  • Its Net Margin stands at 259.54% for Q2 2025, versus 161.94% for Q1 2025 and 212.72% for Q2 2024.